In a rare and urgent joint appeal, Brazilian President Luiz Inácio Lula da Silva and World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus have issued a clarion call to the world’s most powerful leaders. Writing from the distinct vantage points of Brasília and Geneva, they are demanding that the G7, G20, and BRICS nations move beyond diplomatic inertia to finalize the "Pathogen Access and Benefit-Sharing" (PABS) annex—the final, critical component of the landmark WHO Pandemic Agreement.
With a looming deadline of July 17 for the next round of negotiations, the plea represents a final effort to institutionalize global cooperation before the memory of the COVID-19 pandemic fades into the background of a fractured geopolitical landscape.
The Weight of Memory: Why the Agreement Matters
The argument for the Pandemic Agreement is rooted not in bureaucracy, but in the raw, visceral trauma of the early 2020s. For billions, the pandemic was defined by the sound of empty streets, the sight of hospitals pushed beyond their breaking point, and the heartbreak of bidding farewell to loved ones through glass partitions or smartphone screens.
The WHO estimates that the pandemic claimed up to 20 million lives. Beyond the staggering human toll, the International Monetary Fund (IMF) has calculated the economic damage at over $13 trillion in lost global output—a figure reflected in shuttered small businesses, severed supply chains, and a generation of students whose education was abruptly interrupted.
"Humanity promised itself, in the rawness of that grief, that it would not face such a day again unprepared," Lula and Tedros write. The proposed Pandemic Agreement is the manifestation of that promise, designed to replace the fragmented, "every-nation-for-itself" response that characterized the initial COVID-19 outbreak with a structured, equitable framework for identifying and containing future threats.
Chronology: A Race Against Time
The path to the current stalemate has been long and fraught with complex political hurdles.
- May 2023: World Health Assembly members intensify negotiations on a draft agreement, aiming to codify international health security.
- May 1, 2024: The most recent session of negotiations concludes. While significant progress is noted, delegates admit that key issues—specifically regarding how the benefits of shared pathogen data are distributed—remain unresolved.
- June 2024: Mounting pressure from civil society and health experts forces the issue to the center of the global political agenda.
- July 6–17, 2024: The pivotal negotiation window. Negotiators are tasked with closing the remaining gaps to finalize the PABS annex.
The PABS annex is the "final piece of the puzzle." It creates a mechanism where countries that identify a new, dangerous pathogen quickly share its genetic sequence and biological material. In return, the global community guarantees that the resulting vaccines, diagnostics, and treatments will be shared equitably, ensuring that the "have-nots" of the world are not left at the mercy of market forces or protectionist hoarding during a crisis.
Supporting Data: The Case for Urgency
The urgency expressed by the authors is backed by sobering scientific and economic projections. Scientists currently estimate a 25% chance—or one in four—that another pandemic will emerge within the next decade.
The Changing Geography of Risk
The old assumption that pandemics only originate in "distant places" is no longer valid. Climate change, rapid deforestation, and shifts in agricultural land use are altering the habitats of zoonotic pathogens. As these boundaries blur, the risk of "spillover"—where a virus jumps from animal to human—increases globally.
Biotechnology and Biosafety
Simultaneously, the rapid advancement of biotechnology, while a boon for medical research, creates new, unevenly regulated risks. The potential for the accidental or deliberate release of a pathogen is a growing concern for global security, necessitating a unified oversight mechanism that current national frameworks cannot provide.
The Cost of Inaction
As of mid-2024, an Ebola outbreak is already active across two nations, illustrating the reality of our current vulnerability. Without an approved, universally accessible vaccine or cure, frontline health workers are risking their lives in a vacuum of formal international coordination. The cost of such preparedness, the authors argue, is a mere fraction of the $13 trillion loss experienced during COVID-19.
Official Responses and Political Hurdles
The primary obstacle to the agreement remains a profound lack of consensus on the PABS mechanism. Developing nations, led by Brazil and others, argue that if they are to share vital pathogen data, they must be guaranteed "equal footing" when it comes to accessing the medical countermeasures developed from that data. Conversely, some developed nations have expressed concerns regarding the intellectual property rights of pharmaceutical companies and the potential infringement on national sovereignty.
Addressing the Sovereignty Myth
Lula and Tedros addressed the sovereignty concern directly in their letter. They explicitly cite Article 22, paragraph 2 of the draft agreement, which states that the WHO has no authority to direct or alter a country’s domestic laws, mandate lockdowns, or dictate travel restrictions.
"Solidarity is our best immunity," they write. "We ask you to instruct your negotiators to come to the July session ready to conclude, and to give them the flexibility to close the remaining gaps."
Implications: A New Era of Health Security
If the July negotiations succeed, the resulting agreement will mark a historic turning point in human history, comparable to the eradication of smallpox or the global effort to tame polio. The implications of a successful deal are threefold:
- Legal Certainty: Currently, pathogen access is handled on an ad-hoc, case-by-case basis during the height of a crisis. PABS would replace this with a stable, predictable framework, allowing scientists and laboratories to work at the speed required to contain an outbreak before it spreads globally.
- Strategic Equity: Moving beyond moral arguments, the authors frame equity as a matter of global security. "A virus left to burn anywhere will, in time, find everyone," the letter notes. By incentivizing early reporting through equitable benefit-sharing, the world can stop outbreaks at the source, preventing them from becoming global catastrophes.
- The "Deadline vs. Milestone" Mindset: The authors have requested that G7 and G20 leaders publicly declare July 17 a hard deadline. By doing so, they hope to transform the nature of the talks from a procedural negotiation into a definitive act of political will.
The Legacy of Global Health
The appeal concludes with a solemn reminder of the history of international health cooperation. From the global campaign against HIV/AIDS to the fight against tuberculosis and malaria, nations have proven that they can transcend borders for the common good.
"Finishing this Agreement is not a departure from that legacy," the authors assert. "It is its natural next chapter."
As the world watches the negotiators return to the table this July, the message from Brasília and Geneva is clear: the technical hurdles are surmountable, but only if the leaders of the world provide the political mandate to prioritize human survival over the caution of the status quo. The world is waiting to see if its leaders will choose to keep the promise made in the shadow of the last pandemic, or if they will leave the world exposed to the next.
About the Author
